ADPTAdaptive Biotechnologies Corporation Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $14.08 (-4.93% today)

Market Cap: $2.28B

P/E (TTM): -38.10

Analyst Upside: 51.5%

Relative Strength (RS%): 2

-32.2% from 52-week high

Back to Scanner

ADPT

NASDAQRS 2Score 15

Adaptive Biotechnologies Corporation

HealthcareBiotechnology$2.28B1 setup passing
$14.08
-4.9% ($0.73)
-32.2% from 52W High
P/E (TTM)
-38.10
Fwd P/E
PEG
Analyst Upside
+51.5%
EPS Growth
Gross Margin
74.2%
ROE
-30.0%
D/E
1.28
Div Yield
0.0%
Avg Volume
1.6M

Price Chart

Key Levels

SMA 200
$14.63
SMA 50
$15.59
Price
$14.08
52W High
$20.77
Target
$21.33

Setup Radar

1/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst